Nathan Levitan
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 23
- Lung Cancer Research Studies 12
- Neutropenia and Cancer Infections 4
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Rodryg Ramlau (2 shared papers)Yong Kim (2 shared papers)Frances A. Shepherd (2 shared papers)Mark Vincent (2 shared papers)K. Mattson (2 shared papers)J. Bérille (2 shared papers)Ronald L. Burkes (2 shared papers)Susan Coughlin (2 shared papers)
- Journals
- Lung Cancer (8 papers)Journal of Clinical Oncology (7 papers)Cancer (3 papers)CHEST Journal (2 papers)Vox Sanguinis (2 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Nathan Levitan
41 papers receiving 3.2k citations
Nathan Levitan's Hit Papers
Peers
Comparison fields: 5 of 86
- Internal Medicine 596
- Pulmonary and Respiratory Medicine 1.5k
- Oncology 1.2k
- Emergency Medical Services 158
- Hematology 154
Countries citing papers authored by Nathan Levitan
This map shows the geographic impact of Nathan Levitan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Levitan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Levitan more than expected).
Fields of papers citing papers by Nathan Levitan
This network shows the impact of papers produced by Nathan Levitan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Levitan. The network helps show where Nathan Levitan may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan Levitan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy Hit paper breakdown → | 2000 | 1771 |
| 2 | Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data Hit paper breakdown → | 1999 | 727 |
| 3 | 1998 | 120 | |
| 4 | 2004 | 107 | |
| 5 | 2000 | 76 | |
| 6 | 2002 | 74 | |
| 7 | 2014 | 68 | |
| 8 | 2005 | 46 | |
| 9 | 1992 | 34 | |
| 10 | 2000 | 25 | |
| 11 | 1999 | 25 | |
| 12 | 2007 | 24 | |
| 13 | 1995 | 23 | |
| 14 | 2004 | 22 | |
| 15 | 1985 | 22 | |
| 16 | 2001 | 21 | |
| 17 | 2009 | 15 | |
| 18 | 1993 | 13 | |
| 19 | 1985 | 12 | |
| 20 | 1985 | 12 |
About Nathan Levitan
Nathan Levitan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Molecular Biology, having authored 41 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (6 papers), Esophageal Cancer Research and Treatment (4 papers), Neutropenia and Cancer Infections (4 papers), Peptidase Inhibition and Analysis (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Blood groups and transfusion (2 papers). The work is most often cited by research in Internal Medicine (596 citations), Pulmonary and Respiratory Medicine (1.5k citations), Oncology (1.2k citations), Emergency Medical Services (158 citations) and Hematology (154 citations). Nathan Levitan has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Rodryg Ramlau, Yong Kim, Frances A. Shepherd, Mark Vincent, K. Mattson, J. Bérille, Ronald L. Burkes, Susan Coughlin, Richard J. Gralla and Laurent Gressot. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Cancer, CHEST Journal and Vox Sanguinis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.